Arrowhead Pharmaceuticals Cash Flow Statement (2010-2025) | ARWR

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-26.82M-29.92M-63.37M-62.87M44.37M-72.05M-85.94M-41.79M47.68M-104.12M-111.02M-135.38M-127.00M-173.98M-173.34M-175.22M367.86M-178.65M16.12M28.24M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
3.30M15.40M34.62M24.50M28.20M33.39M29.20M19.39M20.61M19.95M18.18M19.69M17.75M17.05M19.47M15.21M16.03M13.04M19.09M19.37M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)
0.82M0.85M0.90M0.26M0.93M
Gains from Investment Securities (Quarter)
3.78M10.20M-63.00M3.22M2.95M-4.43M0.08M2.98M-6.81M0.01M-0.01M0.02M
Non-cash Items (Quarter)
175.29M224.67M149.50M149.31M2.34M
Cash from Operations (Quarter)
263.87M-29.61M-24.03M-61.31M62.73M-68.81M-68.74M-75.52M-31.67M-20.78M-25.93M-117.84M-92.38M-115.42M-137.22M-146.27M460.05M-154.72M20.49M13.48M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.49M0.05M-0.12M0.28M-0.61M-1.68M-0.90M-0.69M0.77M0.95M0.99M0.83M-1.73M-6.99M11.13M5.70M-2.92M1.76M1.24M1.22M
Amortization of Deferred Charges (Quarter)
9.32M16.23M16.14M16.41M14.55M14.90M
Depreciation & Amortization (CF) (Quarter)
1.92M2.00M2.50M2.57M2.59M2.59M2.66M2.69M2.67M3.28M3.86M4.26M4.53M4.78M5.03M5.24M6.08M6.22M6.39M6.39M
Change in Working Capital
Change in Receivables (Quarter)
-8.05M-0.28M9.58M-10.11M1.17M-1.08M1.17M38.16M29.87M-68.19M-1.25M2.50M-0.14M7.48M47.13M212.05M
Change in Inventory (Quarter)
0.45M
Change in Account Payables (Quarter)
0.47M4.74M-0.58M-5.39M6.54M-4.71M-3.03M-2.07M8.76M-1.69M28.00M-12.46M4.06M11.19M-8.32M3.07M-4.79M23.38M-15.38M15.26M
Change in Accured Expenses (Quarter)
1.13M0.41M-0.85M-2.29M5.99M-1.99M16.04M-7.20M-20.08M-4.80M17.12M0.41M-0.42M13.10M19.03M-7.69M26.61M-10.96M33.54M-13.50M
Other Working Capital Changes (Quarter)
0.11M0.17M-2.54M-27.44M0.06M5.55M10.42M-22.98M-76.16M100.96M-1.83M-0.87M0.87M2.24M0.59M20.34M1.41M-19.94M163.36M
Investing Activities
Capital Expenditures (Quarter)
7.17M3.93M8.20M5.78M4.75M9.54M32.71M38.91M-26.08M100.00M63.91M11.29M91.44M-95.82M-2.70M7.52M-7.16M14.82M7.49M0.16M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
13.12M39.59M35.46M38.27M17.51M145.81M69.16M69.42M72.58M78.16M106.57M133.50M75.12M140.03M93.70M118.17M229.23M240.48M101.75M115.34M
Cash from Investing Activities (Quarter)
-34.05M-19.54M-118.25M-33.38M-69.75M61.28M36.45M-80.69M-36.06M-9.90M30.51M64.84M-268.94M6.95M-222.92M76.91M-420.21M141.39M72.62M-23.74M
Financing Activities
Other financing activities (Quarter)
3.13M5.00M
Cash from Financing Activities (Quarter)
2.63M2.75M0.81M1.89M1.85M60.60M0.85M250.58M0.52M1.14M0.82M0.27M430.78M50.39M389.09M20.63M92.38M-42.68M3.67M-14.75M
Additional items
Exchange Rate Effect (Quarter)
-0.04M0.00M-0.03M0.00M-0.12M-0.07M-0.08M0.15M0.06M0.03M-0.22M4.34M-0.07M-0.40M0.09M-0.02M0.11M
Change in Cash (Quarter)
232.46M-46.40M-141.46M-92.81M-5.18M53.06M-31.44M94.37M-67.22M-29.55M5.40M-52.73M69.46M-58.08M28.95M-48.73M132.22M-56.01M96.78M-25.01M
Free Cash Flow (Quarter)
256.71M-33.54M-32.23M-67.09M57.98M-78.35M-101.45M-114.43M-5.59M-120.78M-89.83M-129.13M-183.82M-19.60M-134.51M-153.79M467.21M-169.54M13.00M13.32M
Net Cash Flow (Quarter)
232.46M-46.40M-141.46M-92.81M-5.18M53.06M-31.44M94.37M-67.22M-29.55M5.40M-52.73M69.46M-58.08M28.95M-48.73M132.22M-56.01M96.78M-25.01M